Article L.233-8-II of Commercial Law (Code de commerce) and
Article 223-16 of the General Regulation of the French Financial Markets Authority
(AMF – Autorité des Marchés Financiers)
|
Total number of outstanding shares forming the capital
|
6,410,931 |
|
Total number of outstanding shares forming the capital
|
5,026,359 |
|
Number of shares with double voting rights |
86,640 |
|
Total number of gross voting rights |
5,112,999 |
|
Number of shares without voting rights
|
|
|
Total number of exercisable voting rights* |
5,108,853 |
*Real number of voting rights = total number of voting rights – number of shares without voting rights
If you would like to receive FINANCIAL information about Naturex by e-mail, go to: www.naturex.fr
NATUREX has been listed on segment B of NYSE Euronext Paris since October 1996
|
Number of shares in the capital: 6,410,931 |
About Naturex
NATUREX is the world leader in specialty plant-based ingredients.
The Group, organised around three strategic markets - Food & Beverage, Nutrition & Health and Personal Care -, produces and markets specialty plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetics industries.
Naturex's head office is based in Avignon. Naturex employs 950 people and has high-performance industrial resources across its 11 industrial sites in Europe (France, Italy, Spain, United Kingdom and Switzerland), in Morocco, the United States, Brazil and Australia. The company draws on its worldwide sales presence through a fully dedicated sales network in 19 countries (France, Italy, Spain, United Kingdom, Belgium, Germany, Switzerland, Russia, U.A.E., Thailand, Singapore, Japan, China, Korea, Australia, United States, Canada, Brazil and Mexico).
Naturex enjoys the highly favourable underlying trend linked to increasing demand for natural-origin products and provides manufacturers with personalised solutions in order to meet the expectations of the end consumers. The Group's strength lies in its positioning on specific products which constitute niche markets, thanks to strong sourcing capacity and sustained Research & Development.
| • Contacts | |
| Jacques Dikansky President and Chief Executive Officer Tel.: +33 (0)4 90 23 96 89 naturex@naturex.com |
Thierry Lambert Vice-President Tel.: +33 (0)4 90 23 96 89 t.lambert@naturex.com |
| Carole Alexandre Investor Relations Tel.: +33 (0)4 90 23 78 28 c.alexandre@naturex.com |
Anne Catherine Bonjour Actus Finance Press Relations Tel.: +33 (0)1 53 67 36 93 acbonjour@actus.fr |
